Yeah... Try again. Call the Company and ask how many treatments they have on hand? The fact is it's not many (or said another way, a LOT less than you think), as HGEN had to spend $100+ million just to secure manufacturing and subsequently shut-it down where they could.
From share offerings... $92.5 million from the April 2021 offering, $40 million from selling 2.4 million shares in Q1-Q3 2021, $24.5 million from selling 3.8 million shares in October and early November, $25.0 million from the Hercules Loan, etc., etc. Management loves diluting shareholders every chance they get... Like they did this week, last week, the week before, etc. You should also ask Management what they are forecasting the year-end outstanding share count to be.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.